Monitoring Gesetzessammlung

Gesetze und Verordnungen USA alphabetisch

A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z
0 1 2 3 4 5 6 7 8 9
§ 360bbb–6 - Risk communication
21 USC 360bbb–6
§ 360bbb–7 - Notification
21 USC 360bbb–7
§ 360bbb–8 - Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
21 USC 360bbb–8
§ 360bbb–8a - Optimizing global clinical trials
21 USC 360bbb–8a
§ 360bbb–8b - Use of clinical investigation data from outside the United States
21 USC 360bbb–8b
§ 360bbb–8c - Patient participation in medical product discussion
21 USC 360bbb–8c
§ 360bbb–8d - Notification, nondistribution, and recall of controlled substances
21 USC 360bbb–8d
§ 360c - Classification of devices intended for human use
21 USC 360c
§ 360c–1 - Reporting
21 USC 360c–1
§ 360cc - Protection for drugs for rare diseases or conditions
21 USC 360cc
§ 360ccc - Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
21 USC 360ccc
§ 360ccc–1 - Index of legally marketed unapproved new animal drugs for minor species
21 USC 360ccc–1
§ 360ccc–2 - Designated new animal drugs for minor use or minor species
21 USC 360ccc–2
§ 360d - Performance standards
21 USC 360d
§ 360dd - Open protocols for investigations of drugs for rare diseases or conditions
21 USC 360dd
§ 360ddd - Definitions
21 USC 360ddd
§ 360ddd–1 - Regulation of medical gases
21 USC 360ddd–1
§ 360ddd–2 - Inapplicability of drug fees to designated medical gases
21 USC 360ddd–2
§ 360e - Premarket approval
21 USC 360e
§ 360e–1 - Pediatric uses of devices
21 USC 360e–1
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht